Trial intelligence / Profile preview

Pharmacist vs Physician Prescribing of Oseltamivir for Influenza

NCT01456234Phase 4Terminated

Sponsor
Trial Management Group
Start
Nov 2011
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of oseltamivir in influenza (2 arms), sponsored by Trial Management Group. Primary endpoint: Time from symptom onset to Oseltamivir access at Day 1. Started Nov 2011; status: terminated.

02

Drugs

oseltamivir
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01456234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01456234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call